GlobeNewswire by notified

RESULT RIKSBANK PURCHASES OF CORPORATE BONDS

Share
AuctionResult of auction
Auction date2022-04-27
NameRIKSHEM AB
IsinXS2394028281
Coupon, spread0.425
Maturity2024-10-07
Tendered volume, SEK mln30 +/- 30
Offered volume, SEK mln-
Volume bought, SEK mln-
Number of bids-
Number of accepted bids-
Average yield, DM-
Lowest accepted yield, DM-
Highest yield, DM-
Accepted at lowest yield, %-


AuctionResult of auction
Auction date2022-04-27
NameRIKSHEM AB
Isin XS2112951392
Coupon, spread0.828
Maturity2025-02-03
Tendered volume, SEK mln30 +/- 30
Offered volume, SEK mln-
Volume bought, SEK mln-
Number of bids-
Number of accepted bids-
Average yield, DM-
Lowest accepted yield, DM-
Highest yield, DM-
Accepted at lowest yield, %-


AuctionResult of auction
Auction date2022-04-27
NameWILLHEM AB
IsinSE0013882966
Coupon, spread0.32
Maturity2024-04-08
Tendered volume, SEK mln30 +/- 30
Offered volume, SEK mln-
Volume bought, SEK mln-
Number of bids-
Number of accepted bids-
Average yield, DM-
Lowest accepted yield, DM-
Highest yield, DM-
Accepted at lowest yield, %-


AuctionResult of auction
Auction date2022-04-27
NameWILLHEM AB
IsinSE0013360484
Coupon, spread0.532
Maturity2025-04-01
Tendered volume, SEK mln30 +/- 30
Offered volume, SEK mln-
Volume bought, SEK mln-
Number of bids-
Number of accepted bids-
Average yield, DM-
Lowest accepted yield, DM-
Highest yield, DM-
Accepted at lowest yield, %-


AuctionResult of auction
Auction date2022-04-27
NameASSA ABLOY AB
IsinXS1973714717
Coupon, spread1.00
Maturity2024-04-02
Tendered volume, SEK mln30 +/- 30
Offered volume, SEK mln-
Volume bought, SEK mln-
Number of bids-
Number of accepted bids-
Average yield, DM-
Lowest accepted yield, DM-
Highest yield, DM-
Accepted at lowest yield, %-


AuctionResult of auction
Auction date2022-04-27
NameASSA ABLOY AB
IsinXS1953826549
Coupon, spread0.875
Maturity2023-02-22
Tendered volume, SEK mln30 +/- 30
Offered volume, SEK mln-
Volume bought, SEK mln-
Number of bids-
Number of accepted bids-
Average yield, DM-
Lowest accepted yield, DM-
Highest yield, DM-
Accepted at lowest yield, %-


AuctionResult of auction
Auction date2022-04-27
NameSSAB AB
IsinXS2017329306
Coupon, spread2.75
Maturity2024-06-26
Tendered volume, SEK mln30 +/- 30
Offered volume, SEK mln-
Volume bought, SEK mln-
Number of bids-
Number of accepted bids-
Average yield, DM-
Lowest accepted yield, DM-
Highest yield, DM-
Accepted at lowest yield, %-


AuctionResult of auction
Auction date2022-04-27
NameTELIA COMPANY AB
IsinXS2187605030
Coupon, spread1.125
Maturity2025-06-10
Tendered volume, SEK mln30 +/- 30
Offered volume, SEK mln-
Volume bought, SEK mln-
Number of bids-
Number of accepted bids-
Average yield, DM-
Lowest accepted yield, DM-
Highest yield, DM-
Accepted at lowest yield, %-


AuctionResult of auction
Auction date2022-04-27
NameTELIA CO AB
IsinXS0989164743
Coupon, spread3.625
Maturity2023-11-08
Tendered volume, SEK mln30 +/- 30
Offered volume, SEK mln-
Volume bought, SEK mln-
Number of bids-
Number of accepted bids-
Average yield, DM-
Lowest accepted yield, DM-
Highest yield, DM-
Accepted at lowest yield, %-


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

SeaLegacy Celebrates the Inaugural Year of The Good Ocean17.5.2022 21:49:59 CEST | Press release

A unified, passionate group of businesses investing in SeaLegacy’s mission to protect the world’s oceans British Columbia, Canada, May 17, 2022 (GLOBE NEWSWIRE) -- When eight companies mostly unknown to one another came together for the first time in May of 2021, they were bound only by a commitment to protect our oceans and planet. Today, these founding members of The Good Ocean are actively supporting SeaLegacy’s commitment to ocean protection. "One of the questions I get asked the most is, 'What can I do?'" says SeaLegacy Co-Founder and President Cristina Mittermeier. "This question comes from individuals, and it also comes from businesses. Increasingly, consumers are demanding the products and services they support with their purchasing power be aligned with their desire to be accountable for their impact on earth. Members of The Good Ocean are addressing that demand and stepping into the crucial role businesses play in conservation work. Together, we are taking steps towards syste

Karolinska Development’s portfolio company Aprea Therapeutics acquires Atrin Pharmaceuticals17.5.2022 16:55:38 CEST | Press release

STOCKHOLM, SWEDEN, May 17 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Aprea Therapeutics has completed the acquisition of the privately-held US-based biotechnology company Atrin Pharmaceuticals Inc. Aprea Therapeutics will now prioritize the development of Atrin Pharmaceuticals’ drug candidates, which are being developed to fight cancer by affecting the proteins involved in the ability of tumors to repair damage to their DNA. With the acquisition of Atrin Pharmaceuticals’ portfolio of candidate drugs, Aprea Therapeutics intends to shift its primary focus to the development of ATRN-119, a drug candidate that inhibits an important signaling pathway in DNA damage repair. ATRN-119 will soon be evaluated in clinical phase 1/2a studies in the treatment of malignant solid tumors, both as monotherapy and in combination with standard treatment. In parallel with the development of ATRN-119, separate programs are run with a second-generation ATR i

Karolinska Developments portföljbolag Aprea Therapeutics förvärvar Atrin Pharmaceuticals17.5.2022 16:55:38 CEST | Pressemelding

STOCKHOLM, SVERIGE 17 maj 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Aprea Therapeutics har förvärvat det privatägda amerikanska bioteknikbolaget Atrin Pharmaceuticals Inc. Aprea Therapeutics kommer nu att prioritera utvecklingen av Atrin Pharmaceuticals läkemedelskandidater, vilka utvecklas för att bekämpa cancersjukdomar genom att påverka de proteiner som är involverade i tumörers förmåga att reparera skador i sitt DNA. Efter förvärvet av Atrin Pharmaceuticals läkemedelsprojekt flyttar Aprea Therapeutics sitt primära fokus till utvecklingen av ATRN-119, en läkemedelskandidat som hämmar en viktig signaleringsväg vid reparation av DNA-skador. ATRN-119 kommer inom kort att börja studeras i kliniska fas 1/2a-studier vid behandling av maligna solida tumörer, både som monoterapi och i kombination med standardbehandling. Parallellt med utvecklingen av ATRN-119 bedrivs separata program med en andra generationens ATR-hämmare, ATRN-354, med poten

EXEL Industries: shares and voting rights as of April 30, 202217.5.2022 15:36:23 CEST | Press release

EXEL Industries A French Société Anonyme with a share capital of €16,969,750 Registered office:- France Reims Companies Register (RCS): No. 095 550 356 Number of shares and voting rights Article 223-16 of the AMF regulation DateTotal number of shares comprising the share capitalTotal number of voting rightsApril 30, 20226,787,900Theoretical voting rights: 10,854,278Exercisable voting rights*: 10,852,796 * After deduction of shares without voting rights Attachment EXEL Industries Droits de vote 2022.04.30_EN

Consumers and Employees Call for a New Approach to Corporate Philanthropy: Stakeholder Philanthropy17.5.2022 15:30:00 CEST | Press release

Four in five consumers (84%) and employees (86%) believe that stakeholders should have a say in how a business allocates charitable funds CALGARY, Alberta, May 17, 2022 (GLOBE NEWSWIRE) -- Benevity Inc., a leading provider of global corporate purpose software, today released results of a new survey measuring public sentiment on corporate philanthropy. The findings highlight a growing interest in and expectation of employees and consumers to be involved in corporate philanthropy and call on businesses to consider a new approach that is more stakeholder driven. Businesses that evolve toward this new model of stakeholder philanthropy will benefit financially, with respondents saying they are more likely to buy from, work for and stay with companies who engage them. Benevity’s Engagement in Corporate Giving study found that four of five consumers (84%) and employees (86%) believe they should be able to have a say in how a business allocates its charitable funds. Additionally, 73% of consum